How to best define the metabolic syndrome

Annals of Medicine

Volumn 38, Issue 1, 2006, Pages 34-41

  Magliano, Dianna J ^a   Shaw, Jonathan E ^a   Zimmet, Paul Z ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Central obesity; Insulin resistance; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; CLUSTER ANALYSIS; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 31744447164     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890500300311     Document Type: Review

References (31)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
2. Kylin E. Studien ueber das Hypertonie-Hyperglyka "mie- Hyperurika" miesyndrom. Zentralblatt fuer Innere Medizin. 1923;44:105-27.
3. Vague J, Combes R, Tramoni M, Angeletti S, et al. In: Mancini M, Lewis B, Contaldo F, eds. Medical complications of obesity. London: Academic Press. 1979.
4. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
5. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487-91.
6. Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res. 2002;34:469-74.
7. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr. 2004; 23:963-74.
8. Alexander H, Balding D, Dobson A, et al. Risk factors and heart disease mortality. A regional perspective. Med J Aust. 1986;144:20-2.
9. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes. 2002;51:3120-7.
10. Cameron AJ, Shaw JE, Zimmet PZ. The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinology and metabolism clinics of North America. Metabolic Syndrome: Part 1. 2004;33:351-76.
11. Zimmet P, Boyko EJ, Collier GR, de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann N Y Acad Sci. 1999;892:25-44.
12. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-94.
13. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004; 53:1195-200.
14. American College of Endocrinology Task Force on the Insulin Resistance Syndrome. American College of Endocrinology Position Statement on the Insulin Resistance Syndrome. Endocr Pract. 2003;9:236-52.
15. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Mehta R, Franco A, Olaiz G, et al. The metabolic syndrome: a concept hard to define. Arch Med Res. 2005;36:223-31.
16. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care. 2004; 27:2429-37.
17. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: Department of Non-communicable Disease Surveillance, 1999.
18. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
19. Zimmet P, Alberti G, Shaw J. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust. 2005; 183:175-6.
20. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
21. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004;27:978-83.
22. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414:782-7.
23. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Aimeras N, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-84.
24. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
25. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27:2676-81.
26. Ford ES. Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome: A summary of the evidence. Diabetes Care. 2005;28:1769-78.
27. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182-6.
28. Lackland D, Orchard T, Keil J. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population. International J Epidemiol. 1992;21:236-45.
29. Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord. 1999;23:1136-42.
30. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid A, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: International Diabetes Institute; 2000. 1-56.
31. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.